| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
MRC Genetics Group, McGill University-Montreal Childrens Hospital Research Institute Montreal, Quebec, Canada H3H 1P3
Departments of Medicine and Biochemistry, Queens University Kingston, Ontario, Canada K7L 3N6
Address requests for reprints to: Dr. Harriet S. Tenenhouse, MRC Genetics Group, McGill University-Montreal Childrens Hospital Research Institute, 2300 Tupper Street, Montreal, Quebec H3H 1P3, Canada.
Abstract
The present study was undertaken to evaluate the response of Hyp mice to regulators known to inhibit renal 25-hydroxyvitamin D3-l-hydroxylase (1-hydroxylase) and stimulate renal 25-hydroxyvitamin D-24-hydroxylase (24-hydroxylase). Renal mitochondrial metabolism of 25-hydroxyvitamin D3 (25OHD3) was initially examined in vitamin D- and calciumdeprived normal and mutant mice (with no detectable 24-hydroxylase) treated with either calcium, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], or both calcium + 1,25-(OH)2D3. In normal mice, 1,25-(OH)2D3 treatment was more effective than calcium in turning off 1-hydroxylase and turning on 24-hydroxylase activity; serum calcium, however, was similarly increased by both treatments. Although calcium -I- 1,25-(OH)2D3 did not result in a further change in 25OHD3 metabolism in normal mice, a further elevation in serum calcium was apparent. In Hyp mice, treatment with calcium + 1,25-(OH)2D3 resulted in a greater decrease in 1-hydroxylase and a greater increase in 24- hydroxylase and in serum calcium than treatment with either agent alone. In spite of similar serum calcium levels in both genotypes, 24-hydroxylase was 20-fold, 3-fold, and 8-fold greater in Hyp mice relative to normals treated with calcium, 1,25- (OH)2D3, and calcium + 1,25-(OH)2D3, respectively. Kinetic studies revealed that the maximum velocity (Vmax) for induced 24-hydroxylase was 6-fold greater than normal in Hyp mice whereas the apparent Michaelis-Menten constant (Km) was not different in the two groups of calcium + l,25-(OH)2D3-treated mice.
The effect of 1,25-(OH)2D3 treatment on the above serum and renal parameters was also examined in vitamin D replete normal and Hyp mice. A sharp rise in serum phosphate was observed in l,25-(OH)2D3-treated Hyp mice whereas normal littermates experienced marked hypercalcemia in response to treatment. Renal 24-hydroxylase was significantly stimulated by 1,25-(OH)2D3 treatment in both normal and Hyp mice and genotype differences were not apparent.
The present study demonstrates that 1) vitamin D- and calcium-deprived Hyp mice are more responsive to signals which induce 24-hydroxylase than normal littermates; 2) Vma
for induced 24-hydroxylase is 6-fold greater in Hyp mice than in normal littermates whereas apparent Km is unchanged; 3) the inhibitory control of 1-hydroxylase appears to be intact in the mutant strain; 4) induced 24-hydroxylase is similar in vitamin D replete normal and Hyp mice; and 5) vitamin D status can thus modify the response of both genotypes to treatment with 1,25-(OH)2D3. Clearly, further work will be required to elucidate the mechanism(s) for abnormal regulation of 25OHD3 metabolism in Hyp mouse kidney. (Endocrinology 120: 609–616,1987)
Footnotes
* This work was supported by the MRC Genetics Group Grant (to H.S.T.) and by Grant MA-9475 from the Medical Research Council of Canada (to G.J.) and was presented in part at the 6th Workshop on Vitamin D in Merano, Italy, 1985. This is Publication no. 86025 from the McGill University-Montreal Children's Hospital Research Institute.
Received May 28, 1986.
This article has been cited by other articles:
![]() |
M. H. Meyer, E. Dulde, and R. A. Meyer Jr. The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia Physiol Genomics, June 17, 2004; 18(1): 4 - 11. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |